Skip to main content
Equibles
BMRN logo

BMRN · Biomarin Pharmaceutical Inc

Track BMRN — free

Use BMRN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about BMRN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$67.36 -1.17 (-1.71%) At close · Aug 14
Market Cap
$13.04B
Shares
193.57M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding BMRN

523 fund positions
Fund Balance Value % of Fund Open
Dodge & Cox Stock Fund 9,769,625 $551,886,116 0.48%
iShares Core S&P Mid-Cap ETF 6,360,660 $359,313,683 0.34%
VANGUARD TOTAL STOCK MARKET INDEX FUND 6,120,870 $345,767,946 0.02%
VANGUARD PRIMECAP FUND 5,179,450 $292,587,131 0.40%
VANGUARD CAPITAL OPPORTUNITY FUND 5,109,245 $288,621,250 1.17%
VANGUARD SMALL-CAP INDEX FUND 4,434,414 $250,500,047 0.15%
Capital World Growth & Income Fund 2,576,251 $147,593,420 0.09%
VANGUARD SMALL-CAP GROWTH INDEX FUND 2,482,741 $140,250,039 0.36%
VANGUARD EXTENDED MARKET INDEX FUND 2,145,115 $121,177,546 0.15%
Fidelity Contrafund 1,772,542 $100,130,898 0.06%
State Street SPDR S&P MidCap 400SM ETF Trust 1,447,981 $81,796,447 0.34%
iShares Biotechnology ETF 1,412,330 $79,782,522 0.98%
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,404,601 $79,345,910 1.07%
First Trust NYSE Arca Biotechnology Index Fund 1,368,040 $77,280,580 3.40%
PRIMECAP Odyssey Aggressive Growth Fund 1,398,515 $75,393,944 1.11%
Fidelity Extended Market Index Fund 984,215 $56,385,677 0.13%
Dodge & Cox Balanced Fund 955,200 $53,959,248 0.37%
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF 938,453 $53,013,210 0.34%
PRIMECAP Odyssey Growth Fund 971,226 $52,358,794 0.96%
Dodge & Cox Global Stock Fund 758,500 $42,847,665 0.36%
iShares Russell Mid-Cap ETF 725,506 $40,983,834 0.09%
U.S. SMALL CAP VALUE PORTFOLIO 739,802 $39,882,726 0.21%
American Funds Global Balanced Fund 736,542 $39,706,979 0.12%
VANGUARD EXPLORER FUND 716,403 $38,621,286 0.18%
Fidelity Mid Cap Index Fund 704,210 $37,963,961 0.08%
iShares S&P Mid-Cap 400 Growth ETF 664,986 $37,565,059 0.38%
VANGUARD HEALTH CARE INDEX FUND 548,140 $31,402,941 0.17%
Schwab U.S. Mid-Cap ETF 518,955 $29,730,932 0.20%
THRIVENT SMALL CAP STOCK FUND 489,487 $26,388,244 0.90%
AQR Long-Short Equity Fund 446,215 $25,206,685 0.31%
iShares Russell 1000 Value ETF 437,551 $24,717,256 0.04%
VANGUARD PRIMECAP CORE FUND 426,440 $24,089,596 0.18%
iShares S&P Mid-Cap 400 Value ETF 420,215 $23,737,945 0.30%
Dimensional US Small Cap Value ETF 400,897 $21,612,357 0.29%
Fidelity Contrafund K6 379,550 $21,440,780 0.06%
Fidelity Total Market Index Fund 361,655 $20,719,215 0.01%
U.S. SMALL CAP PORTFOLIO 365,260 $19,691,167 0.10%
Dimensional U.S. Small Cap ETF 361,639 $19,495,958 0.14%
Touchstone Strategic Trust-Touchstone Large Cap Focused Fund 329,786 $18,629,611 0.57%
BlackRock Health Sciences Opportunities Portfolio 322,635 $18,483,759 0.31%
VANGUARD S&P MID-CAP 400 INDEX FUND 306,534 $17,561,333 0.31%
Dimensional U.S. Core Equity 2 ETF 323,150 $17,421,017 0.04%
Fidelity Series Total Market Index Fund 293,592 $16,819,886 0.02%
AQR Equity Market Neutral Fund 283,386 $16,008,475 0.48%
iShares Russell Mid-Cap Value ETF 272,536 $15,395,559 0.11%
Janus Henderson Mid Cap Value Fund 250,694 $14,161,704 0.72%
Schwab Fundamental U.S. Small Company ETF 245,186 $14,046,706 0.16%
iShares Core S&P Total U.S. Stock Market ETF 245,700 $13,879,593 0.02%
Fidelity Enhanced Mid Cap ETF 239,913 $13,552,685 0.23%
Strategic Advisers Fidelity U.S. Total Stock Fund 234,703 $13,446,135 0.01%
Showing 1–50 of 523 positions
Key facts CIK 1048477 CUSIP 09061G101 13F (30d) 543 filings 511 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)